Compare StocksEXPD vs JNJ

Expeditors International of Washington, Inc. (EXPD) vs Johnson & Johnson (JNJ): Which Is the Better Buy in 2026?

As of 2026-06-19, EXPD is overvalued at $161, with a DCF intrinsic value of $101 and a margin of safety of -60%. JNJ is fairly valued at $228, with an intrinsic value of $281 and a margin of safety of 19%. Of the two, JNJ has the wider margin of safety.

EXPD
Expeditors International of Washington, Inc.
$161.32
VS
JNJ
Johnson & Johnson
$228.39

Rewards

EXPD
  • Expeditors International of Washington, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • Share count has been reduced by 13% over the past 4 years through buybacks, increasing each share's claim on earnings.
JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

EXPD
  • Gross margin of 13.6% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Trailing P/E of 26.1x is 28% above the historical average of 20.5x — the stock trades at a premium to its own history.
  • PEG ratio of 3.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
JNJ
  • Trailing P/E of 26.5x is 33% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 3.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $2.4M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
EXPD
JNJ
Valuation
$783.25M
Free Cash Flow
$19.31B
3.71%
FCF Yield
3.51%
26.10
Trailing P/E
26.46
23.65
Forward P/E
17.96
Quality & Moat
32.83%
ROIC
15.32%
36.64%
ROE
26.42%
13.62%
Gross Margin
68.04%
3.77
PEG Ratio
3.06
Balance Sheet Safety
Net cash
Net Debt / Equity
0.41
N/A
Interest Coverage
N/A
-0.66
Net Debt / EBITDA
0.96
0.99%
Dividend Yield
2.22%
EXPD: 5Ties: 2JNJ: 5
EXPDJNJ

Historical Fundamentals

Learn more →
EXPD

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
EXPD
$2.22
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.76B
Δ Market Cap
+$3.91B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EXPD
59.7% Overvalued
Price is 59.7% above estimated fair value
Current Price: $161.32
Fair Value: $101.02
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
JNJ
18.6% Margin of Safety
Price is 18.6% below estimated fair value
Current Price: $228.39
Fair Value: $280.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EXPD

What growth rate is the market pricing in at $161?

+10.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.3%

The market implies +10.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.3%, reflecting heavy growth investment.

JNJ

What growth rate is the market pricing in at $228?

+7.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.3%

The market implies +7.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EXPD
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
EXPD
-2.55
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EXPD
Insiders 0.6%Institutions 101.0%
No. of Institutional Holders1,297
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
JNJ
Insiders 0.1%Institutions 76.9%Retail & Other 23.1%
No. of Institutional Holders5,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EXPD
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EXPD
0
Sells (3M)
8
Sells (12M)
Total value (12M): $6.40M
WALL DANIEL R.
Chief Executive Officer
$884,927
@ $145.07 · 2026-02-27
BELL BLAKE R
Officer
$1.49M
@ $144.08 · 2026-02-27
EMMERT MARK A
Director
$730,350
@ $135.25 · 2025-11-07
DICKERMAN JEFFREY F
General Counsel
$201,255
@ $134.17 · 2025-11-05
CARLILE ROBERT PAUL
Director
$301,268
@ $120.51 · 2025-09-05
EMMERT MARK A
Director
$497,150
@ $121.26 · 2025-08-19
DICKERMAN JEFFREY F
General Counsel
$173,535
@ $118.05 · 2025-08-07
BELL BLAKE R
Officer
$2.12M
@ $117.89 · 2025-08-06
WALL DANIEL R.
Chief Executive Officer
$1.16M
@ $115.91 · 2025-05-12
DICKERMAN JEFFREY F
General Counsel
$146,923
@ $117.54 · 2025-02-20
CARLILE ROBERT PAUL
Director
$363,332
@ $121.11 · 2024-12-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
JNJ
1
Sells (3M)
13
Sells (12M)
Total value (12M): $103.65M
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
DECKER ROBERT J
Officer
$930,113
@ $165.06 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EXPD
FearGreed
😏Greed(64/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
JNJ
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EXPD
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (64)
JNJ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
View EXPD Full AnalysisView JNJ Full Analysis

Frequently Asked Questions: EXPD vs JNJ

Is Expeditors International of Washington, Inc. or Johnson & Johnson more undervalued in 2026?

Based on our discounted cash flow model, JNJ trades at a 18.6% margin of safety (intrinsic value $281 vs. price $228), compared to EXPD's -59.7% margin of safety (intrinsic $101 vs. $161).

Which stock has a wider economic moat, Expeditors International of Washington, Inc. or Johnson & Johnson?

JNJ scores 90/100 (Wide moat), while EXPD scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Which company has better free cash flow, Expeditors International of Washington, Inc. or Johnson & Johnson?

Expeditors International of Washington, Inc. (EXPD) generates a 3.7% free cash flow yield, compared to Johnson & Johnson's 3.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Expeditors International of Washington, Inc. or Johnson & Johnson?

EXPD earns 32.8% ROIC versus JNJ's 15.3%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Expeditors International of Washington, Inc.'s or Johnson & Johnson's?

EXPD's dividend earns a safety score of 94/100 (Very Safe), compared to JNJ's 79/100 (Safe). EXPD has raised its dividend for 3 consecutive years.